BlackRock Institutional Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$150M Buy
3,135,136
+151,644
+5% +$6M 0.02% 702
2016
Q3
$109M Sell
2,983,492
-72,503
-2% -$2.27M 0.02% 830
2016
Q2
$71.2M Buy
3,055,995
+32,301
+1% +$1.04M 0.01% 1035
2016
Q1
$122M Buy
3,023,694
+8,712
+0.3% +$354K 0.02% 734
2015
Q4
$187M Sell
3,014,982
-32,664
-1% -$1.76M 0.03% 569
2015
Q3
$123M Buy
3,047,646
+32,199
+1% +$1.67M 0.02% 732
2015
Q2
$174M Sell
3,015,447
-145,450
-5% -$9.25M 0.03% 626
2015
Q1
$201M Buy
3,160,897
+177,076
+6% +$12M 0.03% 573
2014
Q4
$184M Sell
2,983,821
-104,599
-3% -$5.16M 0.03% 578
2014
Q3
$120M Sell
3,088,420
-121,051
-4% -$4.29M 0.02% 745
2014
Q2
$111M Buy
3,209,471
+77,929
+2% +$2.45M 0.02% 829
2014
Q1
$135M Buy
3,131,542
+39,641
+1% +$1.92M 0.02% 719
2013
Q4
$123M Buy
3,091,901
+28,364
+0.9% +$1.01M 0.02% 742
2013
Q3
$115M Sell
3,063,537
-190,241
-6% -$5.68M 0.02% 708
2013
Q2
$87.4M Buy
+3,253,778
New +$69.2M 0.02% 807

Other funds holding IONS